研究実績

Subgroup analyses of the effect of ramucirumab in pretreatment with immune checkpoint inhibitor in RINDBeRG: a randomized clinical trial in third or further-line treatment of gastric cancer

Ryohei Kawabata, Daisuke Sakai, Shigenori Kadowaki, Takao Tsuduki, Takahisa Suzuki,          Toru Masuzawa, Keitaro Shimozaki, Masahiro Tsuda, Takeshi Yamada, Toshifumi Yamaguchi, Shugo Ueda, Yosuke Kito, Toshiharu Hirose, Tomono Kawase, Takashi Nomura,              Kazuhiro Nishikawa, Hisato Kawakami, Toshio Shimokawa, Narikazu Boku, Taroh Satoh

ASCO-GI 2024, San Francisco California United States 18 Jan – 20 Jan 2024

前の記事 次の記事 一覧ページへ戻る